medRxivGenetic & Genomic MedicinePreprint
Genetic Ethnicity and Hypertension Epistatic Interaction Underlying Racial Disparities in US Multiple Myeloma Susceptibility
Emmanuel LP DumontiD, Luke Han, Srisundesh Kodali, Ariel Alejandro AptekmanniD, Lisa Carter‐HarrisiD, Rena FeinmaniD, Benjamin TyckoiD, David Samuel DiCapua SiegeliD, Andre Henri GoyiD, Peter D. KaplaniD, Catherine DoiD
- Citations
- 1
Abstract
BackgroundMultiple myeloma (MM), a malignant plasma cell disorder, exhibits pronounced racial disparities in incidence and patient outcomes. The Centers for Disease Control and Prevention (CDC) reports that MM is twice as common in Black Americans as in White Americans. Understanding these racial disparities is paramount to addressing potential healthcare biases and developing targeted interventions to ensure equitable patient care and outcomes. MethodsUsing the All of Us database from the National Institute of Health, we performed a retrospective study on 413,457 participants. Of these, 1,430 were diagnosed with MM. We examined the factors contributing to racial disparities in MM risk using multivariable statistical analysis, including interaction effects. ResultsTo comprehensively account for the multidimensional aspects of self-reported race followed by the CDC, we incorporated genetic ethnicity, demographics (age, gender), body mass index, social determinants of health (zipcodes deprivation index, and health insurance status), and common pre-existing comorbidities (hypertension, diabetes, congestive heart failure - CHF, and chronic obstructive pulmonary disease) into our analysis. Our findings reveal that the racial disparities in health outcomes between non-Hispanic Black and non-Hispanic White individuals, as reported by the CDC, are driven by a synergistic epistatic interaction between having African as a predominant genetic ethnicity and being diagnosed or treated for hypertension (OR: 2.92, 95% CI: 1.54 to 5.57, P = 0.001). This interaction is also true for individuals whose primary genetic ancestry is Ad Mixed American (OR: 2.31, 95% CI: 1.02 to 5.2, P = 0.044). The other variables significantly associated with MM risk are having a predominant genetic ancestry of Ad Mixed American (OR: 0.41, 95% CI: 0.2 to 0.85, P = 0.017), the lack of health insurance (OR: 0.67, 95% CI: 0.48 to 0.93, P = 0.017), zipcodes deprivation index being above the US median (OR: 1.26, 95% CI: 1.04 to 1.53, P = 0.018), being diagnosed with CHF before MM (OR: 2.06, 95% CI: 1.56 to 2.72, P < 1.e-3), being male (OR: 1.22, 95% CI: 1.02 to 1.46, P = 0.031), and being over the age of 65 (OR: 1.65, 95% CI: 1.36 to 2, P < 1.e-3). ConclusionThese findings reveal a previously unknown epistatic interaction between an individuals predominant genetic ancestry and hypertension, responsible for the CDC-reported higher risk of the African-American population for MM. In other words, hypertension serves as a surrogate marker for a genetic predisposition in individuals with a predominant African genetic ancestry. This insight could improve the screening and identification of minority individuals at risk for MM.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Relation of Self-Reported Race and Genetic Ancestry to Hypertension Prevalence Among Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos
Raúl A Montañez-Valverde, Vivian Kim, … Carlos J. Rodríguez·medRxiv·Sep 3, 2026
- A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood
Nuzulul Kurniansyah, Matthew O. Goodman, … Tamar Sofer·Nature CommunicationsPeer-reviewed·Jun 21, 2022
- Physical activity reduces the effect of adiposity genetic liability on hypertension risk in the UK Biobank cohort
Chukwueloka Hezekiah, Alexandra I. F. Blakemore, … Raha Pazoki·medRxiv·Sep 22, 2023
- Endometrial cancer survival disparities in women of African ancestry persist beyond clinical, molecular, and socioeconomic determinants
Devin A. Gee, Alisha Daroch, … Marina Frimer·medRxiv·Jun 24, 2026
- Joint Association of Polygenic Risk and Social Determinants of Health with Coronary Heart Disease in the United States
Kristján Norland, Daniel J. Schaid, … Iftikhar J. Kullo·Journal of the American College of CardiologyPeer-reviewed·Nov 1, 2024
- Prediction of Cardiovascular and Renal Complications of Diabetes by a multi-Polygenic Risk Score in Different Ethnic Groups
Edoh Kodji, Redha Attaoua, … Johanne Tremblay·medRxiv·Jun 17, 2025